table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 severe or critically
Immunostimulants drugs
convalescent plasma treatment CAPSID PICP19 ... Duan AlQahtani Ray Li Joyner Sean REMAP-CAP ... Rasheed RECOVER Bihariesingh-Sanchit ... Hegerova Pouladzadeh CP-COVID-19 O’Donnell ILBS-COVID-02 ... PlasmAr Sekine ...
immunoglobulin therapy Raman Tabarsi Gharebaghi
interferon
IFN beta-1a Davoudi-Monfared Kalil ... Darazam ...
IFN beta-1b Darazam ... Rahmani
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo

0 studies excluded by filtering options 2

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons